Quick Answer
Black Diamond Therapeutics, Inc. reported Shares Outstanding of 57.14 million shares for fiscal year 2025.
Black Diamond Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 57.14M | +0.9% |
| 2024 | 56.64M | +9.7% |
| 2023 | 51.65M | +41.7% |
| 2022 | 36.43M | +0.6% |
| 2021 | 36.23M | +0.4% |
| 2020 | 36.08M | +1513.0% |
| 2019 | 2.24M | +2.9% |
| 2018 | 2.17M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 56.94M | +0.7% | +0.1% |
| June 30, 2025 | 56.89M | +0.8% | +0.4% |
| March 31, 2025 | 56.68M | +7.9% | +0.1% |
| December 31, 2024 | 56.64M | +9.7% | +0.2% |
| September 30, 2024 | 56.52M | +9.5% | +0.2% |
| June 30, 2024 | 56.41M | +54.4% | +7.4% |
| March 31, 2024 | 52.53M | +43.9% | +1.7% |
| December 31, 2023 | 51.65M | +41.7% | +0.0% |
- Black Diamond Therapeutics, Inc. showed an increase of +0.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, Black Diamond Therapeutics, Inc.’s shares outstanding has grown by 2528.6% (from 2.17 million shares to 57.14 million shares).
- The most recent figure is from Black Diamond Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: